Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLT PET/CT for ICB Response Assessment
NCT04271436Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2021
- Primary completion
- Jan 2025
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Washington University School of Medicine. Primary endpoint: Change in 18F-FLT uptake at 2 months. Planned start Apr 2021; status: withdrawn.
Beyond the preview
Go deeper on NCT04271436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04271436.